Model Expression in a Pig-to-Human Whole Blood ( 1 , 3 ) Gal α Cytokine Secretion Depends on Gal

[1]  T. Mollnes,et al.  Characterization of Natural Human Anti-Non-Gal Antibodies and Their Effect on Activation of Porcine Gal-Deficient Endothelial Cells , 2007, Transplantation.

[2]  John D Lambris,et al.  Complement and coagulation: strangers or partners in crime? , 2007, Trends in immunology.

[3]  H. Tai,et al.  Progress in xenotransplantation following the introduction of gene‐knockout technology , 2007, Transplant international : official journal of the European Society for Organ Transplantation.

[4]  Zheng Wu,et al.  Cytokine production during the inhibition of acute vascular rejection in a concordant hamster-to-rat cardiac xenotransplantation model. , 2007, Chinese medical journal.

[5]  P. Cowan.  Coagulation and the xenograft endothelium , 2007, Xenotransplantation.

[6]  R. Zhong.  Gal Knockout and Beyond , 2007, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[7]  John D Lambris,et al.  Hydrophobic effect and hydrogen bonds account for the improved activity of a complement inhibitor, compstatin. , 2006, Journal of medicinal chemistry.

[8]  C. Ahn,et al.  Early up‐regulation of CXC‐chemokine expression is associated with strong cellular immune responses to murine skin xenografts , 2006, Xenotransplantation.

[9]  M. Costanzo,et al.  Genetic polymorphism in platelet-derived growth factor and vascular endothelial growth factor are significantly associated with cardiac allograft vasculopathy. , 2006, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[10]  C. Cardella,et al.  The Role of Anti-non-Gal Antibodies in the Development of Acute Humoral Xenograft Rejection of hDAF Transgenic Porcine Kidneys in Baboons Receiving Anti-Gal Antibody Neutralization Therapy , 2006, Transplantation.

[11]  T. Starzl,et al.  Acute rejection is associated with antibodies to non-Gal antigens in baboons using Gal-knockout pig kidneys , 2005, Nature Medicine.

[12]  R. Rieben,et al.  Endothelial cell protection and complement inhibition in xenotransplantation: a novel in vitro model using whole blood , 2005, Xenotransplantation.

[13]  D. Sachs,et al.  α1,3-Galactosyltransferase Gene-Knockout Pig Heart Transplantation in Baboons with Survival Approaching 6 Months , 2005, Transplantation.

[14]  K. Khabar,et al.  Human neutrophil gene expression profiling following xenogeneic encounter with porcine aortic endothelial cells: the occult role of neutrophils in xenograft rejection revealed , 2005, Journal of leukocyte biology.

[15]  M. Murtaugh,et al.  Post‐transplant upregulation of chemokine messenger RNA in non‐human primate recipients of intraportal pig islet xenografts , 2005, Xenotransplantation.

[16]  M. Cybulsky,et al.  Monocyte Adhesion to Xenogeneic Endothelium during Laminar Flow Is Dependent on α-Gal-Mediated Monocyte Activation1 , 2005, The Journal of Immunology.

[17]  S. Yamagami,et al.  Evidence that T-Helper Type 2 Cell-Derived Cytokines and Eosinophils Contribute to Acute Rejection of Orthotopic Corneal Xenografts in Mice , 2005, Transplantation.

[18]  P. Loetscher,et al.  Human Polymorphonuclear Neutrophils are Recruited by Porcine Chemokines Acting on CXC Chemokine Receptor 2, and Platelet-Activating Factor , 2005, Transplantation.

[19]  R. Hawley,et al.  Endothelial Cells Derived from Pigs Lacking Gal&agr;(1,3)Gal: No Reduction of Human Leukocyte Adhesion and Natural Killer Cell Cytotoxicity , 2005, Transplantation.

[20]  A. Zajícová,et al.  The activity of inducible nitric oxide synthase in rejected skin xenografts is selectively inhibited by a factor produced by grafted cells , 2005, Xenotransplantation.

[21]  John D Lambris,et al.  Differential effect of heparin coating and complement inhibition on artificial surface-induced eicosanoid production. , 2005, The Annals of thoracic surgery.

[22]  J. Wood,et al.  Combined Vascular Endothelial Growth Factor and Platelet-Derived Growth Factor Inhibition in Rat Cardiac Allografts: Beneficial Effects on Inflammation and Smooth Muscle Cell Proliferation , 2005, Transplantation.

[23]  R. Rieben,et al.  Lack of Galactose-α-1,3-Galactose Expression on Porcine Endothelial Cells Prevents Complement-Induced Lysis but Not Direct Xenogeneic NK Cytotoxicity1 , 2004, The Journal of Immunology.

[24]  J. Platt,et al.  Pathways to acute humoral rejection. , 2004, The American journal of pathology.

[25]  C. Ahn,et al.  Inducible nitric oxide synthase inhibitors prolonged the survival of skin xenografts through selective down-regulation of pro-inflammatory cytokine and CC-chemokine expressions. , 2003, Transplant immunology.

[26]  O. Korsgren,et al.  Intragraft cytokine mRNA expression in rejecting and non‐rejecting vascularized xenografts , 2003, Xenotransplantation.

[27]  W. Kuziel,et al.  The role of chemokines and their receptors in the rejection of pig islet tissue xenografts , 2003, Xenotransplantation.

[28]  John D Lambris,et al.  Essential role of the C5a receptor in E coli-induced oxidative burst and phagocytosis revealed by a novel lepirudin-based human whole blood model of inflammation. , 2002, Blood.

[29]  C. Marboe,et al.  The role of IL6 cytokines in acute cardiac allograft rejection. , 2002, Transplant immunology.

[30]  R. Moser,et al.  Rolling adhesion of human NK cells to porcine endothelial cells mainly relies on CD49d-CD106 interactions1 , 2002, Transplantation.

[31]  B. N. Day,et al.  Production of α-1,3-Galactosyltransferase Knockout Pigs by Nuclear Transfer Cloning , 2002, Science.

[32]  K. Welsh,et al.  The role of cytokine polymorphisms in rejection after solid organ transplantation , 2001, Genes and Immunity.

[33]  John D Lambris,et al.  A Novel Role of Complement: Mice Deficient in the Fifth Component of Complement (C5) Exhibit Impaired Liver Regeneration1 , 2001, The Journal of Immunology.

[34]  D. Sachs,et al.  Immortalized bone‐marrow derived pig endothelial cells , 2001, Xenotransplantation.

[35]  J. Platt,et al.  Acute vascular rejection. , 2000, Xenotransplantation.

[36]  J. Pickering,et al.  The axis of interleukin 12 and gamma interferon regulates acute vascular xenogeneic rejection , 2000, Nature Medicine.

[37]  J. Platt,et al.  The role of adhesion molecules in human leukocyte attachment to porcine vascular endothelium: implications for xenotransplantation. , 1998, Journal of immunology.

[38]  D. Cooper.  Xenoantigens and xenoantibodies , 1998, Xenotransplantation.

[39]  K. Stuhlmeier,et al.  Human monocytes activate porcine endothelial cells, resulting in increased E-selectin, interleukin-8, monocyte chemotactic protein-1, and plasminogen activator inhibitor-type-1 expression. , 1997, Transplantation.

[40]  S. Gundry,et al.  Serum interleukin-6 level after cardiac xenotransplantation in primates. , 1997, Transplantation proceedings.

[41]  D. Candinas,et al.  T cell independence of macrophage and natural killer cell infiltration, cytokine production, and endothelial activation during delayed xenograft rejection. , 1996, Transplantation.

[42]  John D Lambris,et al.  Inhibition of human complement by a C3-binding peptide isolated from a phage-displayed random peptide library. , 1996, Journal of immunology.

[43]  F. Bach,et al.  Direct activation of porcine endothelial cells by human natural killer cells. , 1996, Transplantation.

[44]  D. White,et al.  The generation of transgenic pigs as potential organ donors for humans , 1995, Nature Medicine.

[45]  J. Platt,et al.  Human complement regulatory proteins protect swine-to-primate cardiac xenografts from humoral injury , 1995, Nature Medicine.

[46]  R. Oriol,et al.  CARBOHYDRATE ANTIGENS OF PIG TISSUES REACTING WITH HUMAN NATURAL ANTIBODIES AS POTENTIAL TARGETS FOR HYPERACUTE VASCULAR REJECTION IN PIG‐TO‐MAN ORGAN XENOTRANSPLANTATION1 , 1993, Transplantation.

[47]  R. Oriol,et al.  Identification of alpha-galactosyl and other carbohydrate epitopes that are bound by human anti-pig antibodies: relevance to discordant xenografting in man. , 1993, Transplant immunology.

[48]  M. Dallman,et al.  Cytokines and their receptors in transplantation. , 1991, Current opinion in immunology.

[49]  E. Appella,et al.  The neutrophil-activating protein (NAP-1) is also chemotactic for T lymphocytes. , 1989, Science.

[50]  S. Shohet,et al.  Man, apes, and Old World monkeys differ from other mammals in the expression of alpha-galactosyl epitopes on nucleated cells. , 1988, The Journal of biological chemistry.

[51]  W. Wilhelmsen,et al.  Serotypes of Neisseria meningitidis isolated from patients in Norway during the first six months of 1978 , 1979, Journal of clinical microbiology.

[52]  R. Rieben,et al.  Xenograft rejection: IgG1, complement and NK cells team up to activate and destroy the endothelium. , 2005, Trends in immunology.

[53]  N. Mueller,et al.  Heart transplantation in baboons using α1,3-galactosyltransferase gene-knockout pigs as donors: initial experience , 2005, Nature Medicine.

[54]  J. Holgersson,et al.  Aberrant expression of alpha-Gal on primary human endothelium does not confer susceptibility to NK cell cytotoxicity or increased NK cell adhesion. , 2004, European Journal of Immunology.

[55]  M. Cassatella.  The production of cytokines by polymorphonuclear neutrophils. , 1995, Immunology today.

[56]  J. Platt,et al.  Mechanism of complement activation in the hyperacute rejection of porcine organs transplanted into primate recipients. , 1992, The American journal of pathology.

[57]  S. H. A. Chen,et al.  Production of α1,3-Galactosyltransferase-Deficient Pigs , 2002, Science.